By: Editorial Staff, Date: June 6th, 2022
If you’re a CEO of a growing company, does it make sense to plan your eventual job end by handing over your position to your employees? For many executive officers, that would probably garner either a cringe or a laugh, but for Heather Payne, it’s the strategic goal for Juno College of Technology in Toronto. If all goes well, Payne will step down as CEO, and the company that she has built as an incubator for startups will transfer to the ownership of her staff.

Employee ownership is a less-traveled road when it comes to company leadership succession. However, instead of selling the company to a competitor, Payne knows that the fundamental direction and nature of her team will instead sustain it forward. After a decade of time and energy in running the decade-old school, employee ownership makes a whole lot of sense. And, on a tax basis, employee ownership shifts may very well become easier. The federal government is considering a revision of the tax code to create an employee ownership trust or EOT. Not official yet, EOTs would essentially make it far more attractive to create employee-owned entities in succession versus transferring a business over in a traditional change. The tax approach would benefit the seller up front with a less painful capital gains hit, while the debt for the sale is absorbed by a trust that in turn is paid off by the company’s continued earnings. Everyone involved then has a stake in making the EOT work.
Proponents point to the trend that EOTs tend to be far more successful and productive because the employees become fully invested in their collective future. And, instead of seeing years’ worth of work turn to dust, former leaders get to see their dreams and work continue to another evolution as a legacy. For Payne, an EOT may very well allow her dream to keep living when she steps away.
Upcoming Webcasts
Hatch-Waxman Case-Law Developments and New Jersey Practice Insights
Navigating the balance between protecting innovation and ensuring access to affordable medications is crucial. Join our speakers in this CLE webcast as they delve into the intricacies of the Hatch-Waxman Act and its profound impact on the pharmaceutical industry. Designed for legal professionals, pharmaceutical executives, and anyone navigating the complex landscape of drug development, this webinar will provide invaluable insights into leveraging Hatch-Waxman strategies to safeguard intellectual property while ensuring broader access to life-saving medications.